🇺🇸 Sildenafil 20 MG in United States

100 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Death — 34 reports (34%)
  2. Hospitalisation — 16 reports (16%)
  3. Pneumonia — 9 reports (9%)
  4. Cardiac Disorder — 7 reports (7%)
  5. Cardiac Failure Congestive — 6 reports (6%)
  6. Dyspnoea — 6 reports (6%)
  7. Therapy Cessation — 6 reports (6%)
  8. Therapy Interrupted — 6 reports (6%)
  9. Drug Dose Omission — 5 reports (5%)
  10. Fluid Retention — 5 reports (5%)

Source database →

Sildenafil 20 MG in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Sildenafil 20 MG approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Sildenafil 20 MG in United States?

National Taiwan University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.